ARD podcast by BMJ talk medicine published on 2014-07-16T18:53:00Z Annals of the Rheumatic Diseases (ARD) is an international peer-reviewed journal committed to promoting the highest standards of scientific exchange and education. It covers all aspects of rheumatology, which includes the spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research. Concise scientific communication is encouraged and peer-reviewed proceedings of international meetings are featured. ARD is the official journal of EULAR. * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others. Contains tracks Innate Lymphoid Cells link TGFb and fibrotic pathways in systemic sclerosis skin by BMJ talk medicine published on 2022-02-07T21:50:06Z Immunogenicity of anti-SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases by BMJ talk medicine published on 2021-07-29T17:01:10Z The EULAR COVID-19 database and its insights into risk factors by BMJ talk medicine published on 2021-03-18T16:35:01Z Predictors of disease worsening in systemic sclerosis by BMJ talk medicine published on 2020-09-15T10:21:12Z Treating Cytokine Storm Syndrome in COVID-19 patients with glucocorticoids and tocilizumab by BMJ talk medicine published on 2020-08-06T16:38:43Z
Innate Lymphoid Cells link TGFb and fibrotic pathways in systemic sclerosis skin by BMJ talk medicine published on 2022-02-07T21:50:06Z
Immunogenicity of anti-SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases by BMJ talk medicine published on 2021-07-29T17:01:10Z
The EULAR COVID-19 database and its insights into risk factors by BMJ talk medicine published on 2021-03-18T16:35:01Z
Predictors of disease worsening in systemic sclerosis by BMJ talk medicine published on 2020-09-15T10:21:12Z
Treating Cytokine Storm Syndrome in COVID-19 patients with glucocorticoids and tocilizumab by BMJ talk medicine published on 2020-08-06T16:38:43Z
